LivaNova stock falls 11% on VNS Therapy study setback [Seeking Alpha]
LivaNova PLC - Ordinary Shares (LIVN)
Last livanova plc - ordinary shares earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
livanova.com
Company Research
Source: Seeking Alpha
RECOVER study for its VNS Therapy product for treatment-resistant depression failed to meet its primary endpoint. The company said that while the study for the cohort group didn't meet the primary endpoint, it did achieve select secondary endpoints. LivaNova plans to conduct an analysis of the data to determine a path forward in the coming weeks , according to a company statement. Researchers plan to publish the unipolar cohort data in peer-reviewed journals in Q4. The bipolar patient cohort of the RECOVER study is ongoing. LivaNova said it will continue to discuss coverage of the therapy for treatment-resistant depression with the Centers for Medicare and Medicaid Services, or CMS. The FDA approved VNS Therapy for the treatment of depression in 2005. The company initiated the RECOVER study in 2019 as part of a Coverage with Evidence Development Framework for the CMS National Coverage Determination process. Recommended For You More Trending News Recommended For You Mor
Show less
Read more
Impact Snapshot
Event Time:
LIVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LIVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LIVN alerts
High impacting LivaNova PLC - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
LIVN
News
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of LivaNova PLC - LIVNPR Newswire
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of LivaNova PLC - LIVNGlobeNewswire
- LivaNova to Announce Second-Quarter 2024 ResultsBusiness Wire
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of LivaNova PLC - LIVNAccesswire
- An Intrinsic Calculation For LivaNova PLC (NASDAQ:LIVN) Suggests It's 31% Undervalued [Yahoo! Finance]Yahoo! Finance
LIVN
Earnings
- 5/1/24 - Beat
LIVN
Sec Filings
- 6/18/24 - Form 4
- 6/18/24 - Form 4
- 6/18/24 - Form 4
- LIVN's page on the SEC website